Cardiovascular

GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension

February 10, 2007
Source: International Stroke Conference, February 6-9, 2007 San Francisco
Christopher Gray

CHRISTOPHER GRAY, University of Newcastle

REFERENCE: Abstract No. LB2
Treating high blood sugar in the acute phases of stroke doesn’t reduce risk of death or severe disability, the GIST – UK (Glucose Insulin in Stroke Trial) has found. This is despite other trials reporting that high glucose levels are associated with increased risk of stroke. Investigators also found that treating glucose levels aggressively lowered blood pressure. To discuss this surprise result, and the background to the trial, Helen Morant talked to Chris Gray.

Add podcast to iTunes

Similar Interviews

  • Aggressive Statin Therapy: Better than Endarterectomy for Patients with Carotid Stenosis?

    • HENRIK SILLESEN, University of Copenhagen REFERENCE: Abstract No. 17 Patients with carotid artery stenosis run much lower risks of further events if

  • Thrombectomy For Acute Stroke: Results of the Multi MERCI Trial

    • WADE SMITH, University of California, San Francisco REFERENCE: Abstract No. LB5 Mechanical removal of the clot that’s causing an acute stroke is

  • MRI Scans Expand Therapeutic Window for Thrombolysis in Stroke

    • PETER SCHELLINGER, University Clinic of Erlangen, Germany REFERENCE: Abstract 2 MRI scanning could make it possible to treat stroke patients safely and

    Post a comment